← All stocks

Faeth Therapeutics, Inc.

FTH Net buying
CIK 0001829802 #2705 in the set updated 17 Sep 2026
Bought (12 mo)
$2.53M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$2.28M
$0.00 on a plan · $82.48K straight out of an exercise
Sold at will
$2.20M
38 of 45 sales
Net
+$250.42K
+$332.89K against sales at will

By person

8 insiders · 96 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
STEPHENSON BRIAN C
Chief Financial Officer
$1.13M (22)
+$1.13M
46,688
$1.13M
Cambrian BioPharma Inc entity
10% owner
$787.81K (10)
−$787.81K
130,142
$3.15M
−28.7%
Peyer James
10% owner
$787.81K (10)
−$787.81K
285,284
$6.91M
−15.5%
MILLENNIUM MANAGEMENT LLC entity
10% owner
$1.34M (26)
$704.45K (25)
+$637.27K
133,986
$3.25M
+21.7%
Parikh Anand Kiran
President and CEO
$55.45K (1)
+$55.45K
817,699
$19.80M
Celebi John
PRESIDENT AND CEO
105,862
$2.56M
−5.0%
van der Horst Edward
CHIEF SCIENTIFIC OFFICER
59,794
$1.45M
−3.7%
Hahn Stephen M.
Director
44,763
$1.08M

No percentages here. This company's share count has moved by a factor of 20.5 over the window, from 1,261,290 to 25,840,425 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Parikh Anand Kiran
22 Jun 2026
President and CEO
Exercised, kept
8,213
$1.16
$9.53K
Parikh Anand Kiran
22 Jun 2026
President and CEO
Exercised, kept
45,252
$1.16
$52.49K

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 38
Transactions with no price 0
Shares from compensation/vesting 860,446
History held since 5 Feb 2021